Lisa Rojkjaer, Chief Medical Officer at Viracta Therapeutics, Inc. (VIRX), sold 2,395 shares at $2.78 ($7K) on 2022-02-28, disclosed to the SEC on 2022-03-01.
Open-market sale of $7k VIRX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VIRX | SELL | 2022-08-29 | $9K | — | Filing → |
| VIRX | SELL | 2022-05-27 | $4K | — | Filing → |
| VIRX | SELL | 2021-11-29 | $22K | — | Filing → |